3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
6
Observational
1
Sponsor
Cancer Type
Breast
15
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Surveys and Questionnaires
58
Blood Specimen Collection
31
Surgical Procedures, Operative
13
Interviews as Topic
13
Immunohistochemistry
13
Data Collection
13
niraparib
12
Hyperthermic Intraperitoneal Chemotherapy
11
Observation
10
Drug Therapy
10
Cytoreduction Surgical Procedures
10
Magnetic Resonance Spectroscopy
9
Radiotherapy
8
Polymerase Chain Reaction
8
Papanicolaou Test
8
Colposcopy
8
Cisplatin
8
Biopsy
8
Amplified Fragment Length Polymorphism Analysis
8
olaparib
7
Carboplatin
7
Ultrasonography
6
Sentinel Lymph Node Biopsy
6
Psychiatric Rehabilitation
6
Paclitaxel
6
Microarray Analysis
6
Laparoscopy
6
Hysterectomy
6
DNA Methylation
6
liposomal doxorubicin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
trastuzumab deruxtecan
×
Gynecologic
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled